Sprites
Dienstag, 21.05.2013Börsentäglich über 11.000 News von 442 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

GENVEC INC

WKN: A1H9WE  ISIN: US37246C3079  Ticker-Symbol: GVC1 
Aktie:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
GENVEC INC Chart 1 Jahr
1-Woche-Intraday-Chart
GENVEC INC 1-Woche-Intraday-Chart
Aktuelle News zur GENVEC Aktie
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
22.03.17
22.03.-
22.03.48
GAITHERSBURG, Md., March 22, 2013 /PRNewswire/ --Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012. For the year ended December...
Mehr lesen zu:
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
15.03.24
GAITHERSBURG, Md., March 15, 2013 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before...
Mehr lesen zu:
GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
12.03.28
GAITHERSBURG, Md., March 12, 2013 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) announced today that Cindy Collins, GenVec's President and CEO, will present a Company overview highlighting recent developments...
Mehr lesen zu:
GenVec to Present at 25th Annual ROTH Conference
11.02.45
ROCKVILLE, Md., Feb. 11, 2013 /PRNewswire/ --BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing...
Mehr lesen zu:
GenVec President & CEO Cynthia Collins Joins BioHealth Innovation, Inc. Board of Directors
17.12.83
GAITHERSBURG, Md., Dec. 17, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ:GNVC) announced today that data were presented on its HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms...
Mehr lesen zu:
Single Administration of GenVec's Vaccine Provides Protective Immunity Against HSV in Pre-clinical Animal Models
14.11.87
GAITHERSBURG, Md., Nov. 14, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's malaria vaccine program at the American Society of Tropical Medicine...
Mehr lesen zu:
Promising Data Presented on GenVec Malaria Program
09.11.34
GAITHERSBURG, Md., Nov. 9, 2012 /PRNewswire/ --Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the three months and nine months ended September 30, 2012. GenVec reported a net...
Mehr lesen zu:
GenVec Reports Third Quarter 2012 Financial Results
02.11.49
GAITHERSBURG, Md., Nov. 2, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) will report financial results for the third quarter ended September 30, 2012 on Friday, November 9, 2012, before the U.S....
Mehr lesen zu:
GenVec To Release Third Quarter 2012 Financial Results And Conduct A Conference Call On November 9, 2012
02.10.49
GAITHERSBURG, Md., Oct. 2, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that it has signed an agreement worth approximately $3.5 million with the Naval Medical Research Center (NMRC)...
Mehr lesen zu:
GenVec Enters Into $3.5 Million Contract With Naval Medical Research Center To Advance Malaria Program
01.10.33
GAITHERSBURG, Md., Oct. 1, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the "8th Annual...
Mehr lesen zu:
Promising Data Presented on GenVec RSV Program
25.09.40
GAITHERSBURG, Md., Sept. 25, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that it is lowering its operating costs to conserve capital including eliminating 23 positions, or approximately...
Mehr lesen zu:
GenVec Announces Reduction in Workforce
09.08.168
GAITHERSBURG, Md., Aug. 9, 2012 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the three months and six months ended June 30, 2012. GenVec reported a net loss...
Mehr lesen zu:
GenVec Reports Second Quarter 2012 Financial Results
02.08.27
GAITHERSBURG, Md., Aug. 2, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the second quarter ended June 30, 2012 on Thursday, August 9, 2012, before the U.S. financial...
Mehr lesen zu:
GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
07.06.43
GAITHERSBURG, Md., June 7, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) has issued...
Mehr lesen zu:
GenVec Announces Conditional Approval of FMD Vaccine for Cattle
25.05.172
GAITHERSBURG, Md., May 25, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) announced today that on May 23, 2012 it granted an option to purchase shares of its common stock to Cynthia...
Mehr lesen zu:
GenVec Reports Inducement Award
21.05.29
GAITHERSBURG, Md., May 21, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC)today announced that effective May 23, 2012 Cynthia Collins has been appointed as President and Chief Executive Officer. In...
Mehr lesen zu:
GenVec Appoints Cynthia Collins as President and CEO
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
GENVEC INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
EVOTEC2,81-0,28 %Evotec: Kurs der Aktie hat weiteres Potenzial
CELL THERAPEUTICS0,94+6,09 %Cell Therapeutics to Present at Upcoming Investor Conferences
VICAL2,759+0,25 %Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
GENEREX BIOTECHNOLOGY0,020 %Generex Comments on Results of Stockholders' Meeting
MEDIGENE0,96+2,45 %Medigene-Aktie feiert Studienergebnisse mit EndoTAG
Lade...
Aufklappen
Schliessen